申请人:Nissan Chemical Industries, Ltd.
公开号:EP2228435A1
公开(公告)日:2010-09-15
An object of the present invention is to expand CD34+ cells ex vivo efficiently in a short term using a biologically safe and inexpensively obtainable low molecular weight compound. A still another object of the present invention is to provide an expansion agent for CD34+ cells useful for treatment of various hematopoietic disorders caused by dysfunctional hematopoietic stem cells and/or hematopoietic progenitor cells.
A method for expanding CD34+ cells, which comprises culturing CD34+ cells ex vivo in the presence of a compound represented by the formula (I) (wherein A, B, L1, L2, L3, L4, R1, R2, R3, X and Y are defined in the description), a tautomer or pharmaceutically acceptable salt of the compound or a solvate thereof.
本发明的一个目的是利用一种生物安全且廉价的低分子量化合物,在短期内有效地扩增体内外的CD34+细胞。本发明的另一个目的是提供一种CD34+细胞扩增剂,用于治疗由造血干细胞和/或造血祖细胞功能障碍引起的各种造血疾病。
一种扩增CD34+细胞的方法,它包括在存在由式(I)代表的化合物(其中A、B、L1、L2、L3、L4、R1、R2、R3、X和Y在描述中定义)、该化合物的同系物或药学上可接受的盐或其溶液的情况下,体外培养CD34+细胞。